RESUMO
Circadian rhythms play important roles in regulating physiological and behavioral processes. These are adjusted by environmental cues, such as diet, which acts by synchronizing or attenuating the circadian rhythms of peripheral clocks, such as the liver, intestine, pancreas, white and brown adipose tissue, lungs, kidneys, as well as the heart. Some studies point to the influence of diet composition, feeding timing, and dietary restriction on metabolic homeostasis and circadian rhythms at various levels. Therefore, this systematic review aimed to discuss studies addressing the effect of diet on the heart clock in animal models and, additionally, the chronodisruption of the clock and its relation to the development of cardiovascular disorders in the last 15 years. A search was conducted in the PubMed, Scopus, and Embase databases. The PRISMA guide was used to construct the article. Nineteen studies met all inclusion and exclusion criteria. In summary, these studies have linked the circadian clock to cardiovascular health and suggested that maintaining a robust circadian system may reduce the risks of cardiometabolic and cardiovascular diseases. The effect of time-of-day-dependent eating on the modulation of circadian rhythms of the cardiac clock and energy homeostasis is notable, among its deleterious effects predominantly in the sleep (light) phase and/or at the end of the active phase.
RESUMO
The scope of this study was to evaluate the effects of a public program of application of botulinum toxin type A (BoNT-A) in terms of muscle spasticity, range of motion, quality of gait, functional independence and quality of life of children and adolescents with cerebral palsy (CP). A quasi-experimental study was conducted with 14 children with CP to evaluate the effects of three applications of BoNT-A, at intervals of three months. Children were assessed using the Modified Ashworth Rating Scale, the Manual Goniometer, the Physician Rating Scale, the Pediatric Evaluation of Disability Inventory (PEDI) and the Caregiver Questionnaire (CQ). There was a reduction of spasticity, an increase in the range of motion, an improvement of the functional abilities of self-care and mobility of PEDI and the areas of personal care, comfort and interaction/communication with the CQ. The BoNT-A application program for children and adolescents with CP, conducted in a public rehabilitation service in the Jequitinhonha Valley, was effective for the targeted population.
Assuntos
Toxinas Botulínicas Tipo A/uso terapêutico , Paralisia Cerebral/complicações , Espasticidade Muscular/tratamento farmacológico , Espasticidade Muscular/etiologia , Fármacos Neuromusculares/uso terapêutico , Adolescente , Brasil , Criança , Pré-Escolar , Avaliação da Deficiência , Feminino , Humanos , Masculino , Avaliação de Programas e Projetos de SaúdeRESUMO
O objetivo do estudo foi avaliar os efeitos de um programa público de aplicação de toxina botulínica tipo A (TBA) na espasticidade muscular, amplitude de movimento, qualidade da marcha, independência funcional e qualidade de vida de crianças e adolescentes com paralisia cerebral (PC). Foi realizado um estudo quase experimental que avaliou os efeitos do emprego da TBA, aplicada três vezes, com intervalos de três meses, em 14 crianças com PC. Estas foram avaliadas através da Escala Modificada de Ashworth, Goniometria Manual, Physician Rating Scale, Inventário de Avaliação Pediátrica de Incapacidade (PEDI) e Questionário do Cuidador da Criança (QCC). Foi observada redução da espasticidade, aumento da amplitude de movimento, melhora das habilidades funcionais de autocuidado e mobilidade do PEDI e das áreas de cuidado pessoal, conforto e interação/comunicação do QCC. O programa de aplicação de TBA em crianças e adolescentes com PC, realizado em um núcleo de reabilitação público do Vale do Jequitinhonha, foi efetivo para a população beneficiada.
The scope of this study was to evaluate the effects of a public program of application of botulinum toxin type A (BoNT-A) in terms of muscle spasticity, range of motion, quality of gait, functional independence and quality of life of children and adolescents with cerebral palsy (CP). A quasi-experimental study was conducted with 14 children with CP to evaluate the effects of three applications of BoNT-A, at intervals of three months. Children were assessed using the Modified Ashworth Rating Scale, the Manual Goniometer, the Physician Rating Scale, the Pediatric Evaluation of Disability Inventory (PEDI) and the Caregiver Questionnaire (CQ). There was a reduction of spasticity, an increase in the range of motion, an improvement of the functional abilities of self-care and mobility of PEDI and the areas of personal care, comfort and interaction/communication with the CQ. The BoNT-A application program for children and adolescents with CP, conducted in a public rehabilitation service in the Jequitinhonha Valley, was effective for the targeted population.